Benzene as a cause of lymphoproliferative disorders

Chemico-Biological Interactions

Volumn 184, Issue 1-2, 2010, Pages 147-150

  Goldstein, Bernard D ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Benzene; Causality; Genotoxicity; Lymphoma; Mechanism

Indexed keywords

BENZENE;

ARTICLE; BONE MARROW TUMOR; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOMAL PARAMETERS; CHRONIC LYMPHATIC LEUKEMIA; GENOTOXICITY; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHATIC SYSTEM TUMOR; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE MYELOMA; MYELOID LEUKEMIA; NONHODGKIN LYMPHOMA; NONHUMAN;

ANIMALS; BENZENE; DNA DAMAGE; HUMANS; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MICE;

EID: 77950628146     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.12.021     Document Type: Article

References (54)

1. International Agency for Research on Cancer (IARC), Summaries and Evaluations: Benzene, Supplement 7, (1987) 120-122.
2. Report on Carcinogens, eleventh edition, U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, (accessed 2009). http://ntp.niehs.nih.gov/ntp/roc/toc11.html.
3. Cogliano V.J., Baan R.A., Straif K., Grosse Y., Secretan B., El Ghissassi F. Use of mechanistic data in IARC evaluations. Environ. Mol. Mutagen. 2008, 49:100-109.
4. National Toxicology Program, Listing Criteria, (accessed 2009, last updated 2008). http://ntp.niehs.nih.gov/index.cfm?objectid=03C9CE38-E5CD-EE56-D21B94351DBC8FC3.
5. Infante P.F., Rinsky R.A., Wagoner J.K., Young R.J. Leukaemia in benzene workers. Lancet 1977, 2:76-78.
6. Vigliani E.C., Saita G. Benzene and leukemia. N. Engl. J. Med. 1964, 271:872-876.
7. Aksoy M. Benzene as a leukemogenic and carcinogenic agent. Am. J. Ind. Med. 1985, 8:9-20.
8. Vigliani E.C., Forni A. Benzene, chromosome changes and leukemia. J. Occup. Med. 1969, 11:148-149.
9. Infante P.F. Benzene: an historical perspective on the American and European occupational setting. Late Lessons from Early Warnings: the Precautionary Principle 1896-2000 2001, 38-51. European Environmental Agency, Copenhagen. P. Harremoës, D. Gee, M. MacGarvin, A. Stirling, J. Keys, B. Wynne, S. Guedes Vaz (Eds.).
10. Snyder C.A., Goldstein B.D., Sellakumar A., Bromberg I., Laskin S., Albert R.E. The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57BL/6J mice. Toxicol. Appl. Pharmacol. 1980, 54:323-331.
11. Cronkite E.P. Benzene hematotoxicity and leukemogenesis. Blood Cells 1986, 12:129-137.
12. Huff J.E., Haseman J.K., DeMarini D.M., Eustis S., Maronpot R.R., Peters A.C., Persing R.L., Chrisp C.E., Jacobs A.C. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect. 1989, 82:125-163.
13. Maltoni C., Ciliberti A., Cotti G., Conti B., Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ. Health Perspect. 1989, 82:109-124.
14. Farris G.M., Everitt J.I., Irons R.D., Popp J.A. Carcinogenicity of inhaled benzene in CBA mice. Fundam. Appl. Toxicol. 1993, 20:503-507.
15. NTP report on the toxicology and carcinogenesis study of benzene (CAS No. 71-43-2) in genetically modified haploinsufficient p16 Ink4a/p19 Arf mice (gavage study). Natl. Toxicol. Program. Genet. Modif. Model. Rep. 2007, (8):1-81.
16. Kawasaki Y., Hirabayashi Y., Kaneko T., Kanno J., Kodama Y., Matsushima Y., Ogawa Y., Saitoh M., Sekita K., Uchida O. Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice. Toxicol. Sci. 2009, 110:293-306.
17. Swerdlow S.H., Campo E., Harris N., Jaffe E., Pileri S., Stein H., Thiele J., Vardiman J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008, International Agency for Research on Cancer (IARC).
18. Mani H., Jaffe E.S. Hodgkin lymphoma: an update on its biology with new insights into classification. Clin. Lymphoma Myeloma 2009, 9:206-216.
19. Forni A. Chromosome changes and benzene exposure. A review. Rev. Environ. Health 1979, 3:5-17.
20. Zhang L., Eastmond D.A., Smith M.T. The nature of chromosomal aberrations detected in humans exposed to benzene. Crit. Rev. Toxicol. 2002, 32:1-42. 10.1080/20024091064165.
21. Goldstein B.D. Benzene toxicity. State Art Rev. Occup. Med. 1998, 3:541-554.
22. Rothman N., Smith M.T., Hayes R.B., Li G.L., Irons R.D., Dosemeci M., Haas R., Stillman W.S., Linet M., Xi L.Q., Bechtold W.E., Wiemels J., Campleman S., Zhang L., Quintana P.J., Titenko-Holland N., Wang Y.Z., Lu W., Kolachana P., Meyer K.B., Yin S. An epidemiologic study of early biologic effects of benzene in Chinese workers. Environ. Health Perspect. 1996, 104(Suppl. 6):1365-1370.
23. Zhang L., Rothman N., Wang Y., Hayes R.B., Bechtold W., Venkatesh P., Yin S., Wang Y., Dosemeci M., Li G., Lu W., Smith M.T. Interphase cytogenetics of workers exposed to benzene. Environ. Health Perspect. 1996, 104(Suppl. 6):1325-1329.
24. Tompa A., Jakab M.G., Major J. Risk management among benzene-exposed oil refinery workers. Int. J. Hyg. Environ. Health 2005, 208:509-516.
25. Pandey A.K., Bajpayee M., Parmar D., Kumar R., Rastogi S.K., Mathur N., Thorning P., de Matas M., Shao Q., Anderson D., Dhawan A. Multipronged evaluation of genotoxicity in Indian petrol-pump workers. Environ. Mol. Mutagen. 2008, 49:695-707.
26. Navasumrit P., Chanvaivit S., Intarasunanont P., Arayasiri M., Lauhareungpanya N., Parnlob V., Settachan D., Ruchirawat M. Environmental and occupational exposure to benzene in Thailand. Chem. Biol. Interact. 2005, 153-154:75-83.
27. Bogadi-Sare A., Brumen V., Turk R., Karacic V., Zavalic M. Genotoxic effects in workers exposed to benzene: with special reference to exposure biomarkers and confounding factors. Ind. Health 1997, 35:367-373.
28. Goldstein B.D. Occam's razor is dull. Environ. Health Perspect. 1989, 82:3-6.
29. Gassmann W., Loffler H., Thiel E., Ludwig W.D., Schwartz S., Haferlach T., Maurer J., Rieder H., Fonatsch C., Gokbuget N., Hoelzer D. Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German Multicentre ALL Study Group (GMALL). Br. J. Haematol. 1997, 97:372-382.
30. Xavier A.C., Ge Y., Taub J.W. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 William Beaumont Hospital Symposium on molecular pathology. J. Mol. Diagn. 2009, 11:371-380. 10.2353/jmoldx.2009.080132.
31. Lee S.G., Choi J.R., Kim J.S., Park T.S., Lee K.A., Song J. Therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2):a case study and review of the literature. Cancer Genet. Cytogenet. 2009, 191:51-54.
32. Calabretta B., Perrotti D. The biology of CML blast crisis. Blood 2004, 103:4010-4022.
33. Savitz D., Andrews K.W. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am. J. Ind. Med. 1997, 31:287-295.
34. Blair A. Occupational exposures and non-Hodgkin lymphoma: where do we stand?. Occup. Environ. Med. 2006, 63:1-2.
35. Chiu B.C.H., Weisenburger D.D. An update of the epidemiology of non-Hodgkin's lymphoma. Clin. Lymphoma Myeloma 2003, 4:161-168.
36. Alexander D.D., Mink P.J., Adami H., Chang E.T., Cole P., Mandel J.S., Trichopoulos D. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int. J. Cancer 2007, 120:1-39.
37. Arnetz B.B., Raymond L.W., Nicolich M.J. Mortality among petrochemical science and engineering employees. Arch. Environ. Health 1991, 46:237-248.
38. Hayes R.B., Yin S.N., Dosemeci M., Li G.L., Wacholder S., Travis L.B., Li C.Y., Rothman N., Hoover R.N., Linet M.S. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. J. Natl. Cancer Inst. 1997, 89:1065-1071. [see Comments].
39. Kristensen P., Hilt B., Svendsen K., Grimsrud T.K. Incidence of lymphohaematopoietic cancer at a university laboratory: a cluster investigation. Eur. J. Epidemiol. 2008, 23:11-15. 10.1007/s10654-007-9203-5.
40. Fabbro-Peray P., Daures J., Rossi J. Environmental risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Languedoc-Roussillon, France. Cancer Causes Control 2001, 12:201-212.
41. Costantini A.S., miligi L., Kriebel D., Ramazzotti V., Rodella S., Scarpi E., Stagnaro E., Tumino R., Fontana A., Masala G., Vigano C., Vindigni C., Crosignani P., Benvenuti A., Vineis P. A Multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology 2001, 12:78-87.
42. Bloeman L.J., Youk A., Bradley T.D., Bodner K.M., Marsh G. Lymphohaematopoietic cancer risk among chemical workers exposed to benzene. J. Occup. Environ. Med. 2004, 61:270-274.
43. Raabe G.K., Collingwood K.W., Wong O. An updated mortality study of workers at a petroleum refinery in Beaumont, Texas. Am. J. Ind. Med. 1998, 33:61-81.
44. Divine B.J., Hartman C.M., Wendt J.K. Update of the Texaco mortality study 1947-93. Part II. Analyses of specific causes of death for white men employed in refining, research, and petrochemicals. Occup. Environ. Med. 1999, 56:174-180.
45. Wong O. An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results. Br. J. Ind. Med. 1987, 44:365-381.
46. Glass D.C., Gray C.N., Jolley D.J., Gibbons C., Sim M.R., Fritschi L., Adams G.G., Bisby J.A., Manuell R. Leukemia risk associated with low-level benzene exposure. Epidemiology 2003, 14:569-577.
47. Girard R., Prost G., Tolot F. Comments on indemnification for benzene induced leukemia and aplasia. Arch. Mal. Prof. Med. Trav. Secur. Soc. 1971, 32:581-583.
48. Marsh G.M., Enterline P.E., McCraw D. Mortality patterns among petroleum refinery and chemical plant workers. Am. J. Ind. Med. 1991, 19:29-42.
49. Blair A., Purdue M.P., Weisenburger D.D., Baris D. Chemical exposures and risk of chronic lymphocytic leukaemia. Br. J. Haematol. 2007, 139:753-761.
50. Goldstein B.D. Letter to the Editor re: Glass et al. Leukemia risk associated with low-level benzene exposure. Epidemiology 2004, 15:509-510.
51. Wong O., Raabe G.K. Non-Hodgkin's lymphoma and exposure to benzene in a multinational cohort of more than 308,000 petroleum workers, 1937 to 1996. J. Occup. Environ. Med. 2000, 42:554-568.
52. Smith M.T., Jones R.M., Smith A.H. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:385-391.
53. Steinmaus C., Smith A.H., Jones R.M., Smith M.T. Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup. Environ. Med. 2008, 65:371-378.
54. Infante P.F. Benzene exposure and multiple myeloma: a detailed meta-analysis of benzene cohort studies. Ann. N.Y. Acad. Sci. 2006, 1076:90-109.